Skip to content

Resource Tags: Converging Therapeutics

Ali Punjani

CEO, Structura Biology

Ali Punjani is CEO of Structura Biotechnology Inc, a Toronto startup working at the intersection of computer science and biology, specifically on a revolutionary Nobel-prize winning structural biology technique called cryo-electron microscopy (cryo-EM). Structura’s algorithms and software tools are used by thousands of scientists globally to solve 3D atomic resolution structures of proteins, complexes and […]

Read More
Arpita Maiti

Executive Director & Global Head, Emerging Science & Innovation Lead – Inflammation & Immunology, Pfizer

As Executive Director and Global Head for Inflammation & Immunology, Emerging Science & Innovation (ES&I), Arpita leads scouting of external opportunities (Idea to Candidate) and academic collaborations for the Inflammation & Immunology (I&I) research unit and the Centers for Therapeutic Innovation (CTI), at Pfizer. She also leads strategy and partnering efforts in the microbiome for […]

Read More
Sunita Malhotra

Director, Search and Evaluation, AbbVie

Sunita holds the position of Director, Academic Outreach and Alliance Management at AbbVie, where she focuses on academic outreach to institutions across North America. Sunita also manages the out-licensing portfolio for AbbVie. Sunita has more than 20 years of pharmaceutical industry experience, out of which last 10 years have been with Abbott and then AbbVie. […]

Read More
Dr. Natalia Martin Orozco

VP, Providence Therapeutics

Dr. Natalia Martin Orozco serves as the VP of Drug Development for Providence Therapeutics. She leads the research, development and manufacturing team for development of personalized mRNA vaccines. Dr. Martin, came from the United States, where she worked leading teams in big pharmaceuticals, such as EMD Serono as well as small biotech companies such as […]

Read More
Philip Tagari

VP Research, Amgen

Philip Tagari is currently Vice President of Research (Therapeutic Discovery) at Amgen Inc, the world’s largest independent biotechnology company. His global laboratories (US, Canada, Germany, China, India) are responsible for biologics discovery, scaffold engineering, optimization and early manufacturability assessment; medicinal, oligonucleotide and peptide chemistry; protein conjugates (Ab-RNAi, peptibodies) and reagents; assay development, screening, enzymological and […]

Read More
Brent Stead

CEO, Specific Biologics

Brent is co-founder and CEO of Specific Biologics, a discovery stage company developing gene editing technologies for therapeutic use. Prior to Specific Biologics, Brent worked for 7 years in the biotechnology industry in various capacities, most recently in business development for a biologics development and manufacturing organization. He started his career in the life sciences […]

Read More
Dr. Sheila Singh

CEO, Empirica Therapeutics

Dr. Sheila Singh is a professor of surgery and biochemistry, chief pediatric neurosurgeon at McMaster Children’s Hospital, Division Head of Neurosurgery at Hamilton Health Sciences, and scientist appointed to the Stem Cell and Cancer Research Institute at McMaster University. She holds a Tier 1/ Senior Canada Research Chair in Human Brain Cancer Stem Cell Biology, […]

Read More
Joseph Geraci

CEO, NetraMark Corp

Dr. Joseph Geraci is the CEO of NetraMark Corp which is a start-up specializing in optimizing clinical trials and drug repurposing/resurrection for age related diseases and oncology. Their technology accomplishes this by cracking open complex patient populations via a new way to perform explainable machine learning. The NetraAI technology is capable of providing novel insights […]

Read More
Daniel Cohen

Co-founder and CEO, InVivo AI

Daniel is a co-founder and CEO at InVivo AI, a startup out of Mila developing novel algorithms for data-efficient deep learning and generative drug design. Previously, he was a member of the investment team at Lumira Ventures and Front Row Ventures. Daniel holds degrees in neuroscience and computer science and a master’s degree in computational […]

Read More